Here's What Key Metrics Tell Us About VAREX IMAGING (VREX) Q3 Earnings

Core Insights - VAREX IMAGING reported revenue of $203 million for the quarter ended June 2025, a decrease of 2.9% year-over-year, but exceeded the Zacks Consensus Estimate of $190.2 million by 6.73% [1] - The company's EPS was $0.18, up from $0.14 in the same quarter last year, resulting in a significant EPS surprise of 350% compared to the consensus estimate of $0.04 [1] Revenue Breakdown - Industrial revenue was $60.9 million, surpassing the average estimate of $57.09 million by two analysts, reflecting a year-over-year increase of 0.7% [4] - Medical revenue totaled $142.1 million, which was above the average estimate of $133.17 million, but represented a decline of 4.4% year-over-year [4] Profitability Metrics - Gross profit for the Industrial segment was $20.8 million, exceeding the average estimate of $18.11 million [4] - Gross profit for the Medical segment was $46.7 million, also above the estimated $42.27 million by two analysts [4] Stock Performance - VAREX IMAGING shares have declined by 16.5% over the past month, contrasting with a 1.2% increase in the Zacks S&P 500 composite [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating expected performance in line with the broader market in the near term [3]